Question 1

What are the new biomarkers being tested, and how might they help in understanding my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Prognostic Value of Three New Biomarkers of Multiple Sclerosis in Patients With Radiologically Isolated Syndrome clinical trial (NCT03357887). Contact the study team or your healthcare provider for specific answers.

Question 2

How does the analysis of these biomarkers compare to the standard reference biomarker?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Prognostic Value of Three New Biomarkers of Multiple Sclerosis in Patients With Radiologically Isolated Syndrome clinical trial (NCT03357887). Contact the study team or your healthcare provider for specific answers.

Question 3

What does the process of providing my cerebrospinal fluid and serum samples involve?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Prognostic Value of Three New Biomarkers of Multiple Sclerosis in Patients With Radiologically Isolated Syndrome clinical trial (NCT03357887). Contact the study team or your healthcare provider for specific answers.

Question 4

How will the results of this study impact my treatment options or management of my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Prognostic Value of Three New Biomarkers of Multiple Sclerosis in Patients With Radiologically Isolated Syndrome clinical trial (NCT03357887). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any risks or side effects associated with participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Prognostic Value of Three New Biomarkers of Multiple Sclerosis in Patients With Radiologically Isolated Syndrome clinical trial (NCT03357887). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I decide to withdraw from the study after participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Prognostic Value of Three New Biomarkers of Multiple Sclerosis in Patients With Radiologically Isolated Syndrome clinical trial (NCT03357887). Contact the study team or your healthcare provider for specific answers.

What this study is about